PAR — Par Drugs and Chemicals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.24bn
- IN₹966.13m
- IN₹1.01bn
- 70
- 82
- 23
- 64
Annual cashflow statement for Par Drugs and Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | — | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 147 | 127 | 151 | 195 | 179 |
| Depreciation | |||||
| Non-Cash Items | -15.2 | 1.8 | -2.09 | -3.48 | -10.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -39.4 | -85.5 | -47.3 | -23.6 | -43.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 121 | 76.2 | 134 | 202 | 162 |
| Capital Expenditures | -50.5 | -32 | -76.3 | -60.8 | -12.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 51 | 1.84 | 2.96 | 2.42 | -240 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.507 | -30.2 | -73.4 | -58.4 | -252 |
| Financing Cash Flow Items | -6.03 | -3.76 | -0.024 | 0 | 0 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 16.5 | -95.5 | -0.024 | 0 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 138 | -49.6 | 60.4 | 144 | -90.8 |